Resmed Inc. · NYSE:RMD
Resmed — Merger or Acquisition (February 2016)
11 slides from Resmed's merger presentation, Feb 22, 2016
Slide 1: ResMed Inc. Acquisition of Brightree
ResMed Inc. Acquisition of Brightree February 22, 2016 Exhibit 99.2
Slide 2: Forward Looking Statements
Forward Looking Statements Statements contained in this presentation that are not historical facts are “forward-looking” statements as contemplated by the Private Securities Litigation Reform Act of 1995. These forward-looking statements — including statements regarding ResMed's projections of futur
Slide 3: Transaction Overview – Accretive after close
Transaction Overview – Accretive after close $800 million, all cash 2015 EBITDA multiple: 13.5x with tax benefits, 18.8x without Closing expected by the end of Q4 fiscal year 2016, subject to customary conditions Transaction Accretive to Non-GAAP EPS after close and continues to be accretive in subs
Slide 4: Strategic Rationale – Reinforces ResMed's tech-driven focus
Strategic Rationale – Reinforces ResMed’s tech-driven focus Strengthens ResMed’s global leadership in connected care solutions Adds to growth opportunities for software revenues Complements ResMed’s Air Solutions platform Creates expansion opportunities in home health, hospice and post-acute coordin
Slide 5: Brightree – Profitable with strong financials
Brightree – Profitable with strong financials Business Overview Headquarters: Atlanta, GA Year founded: 2002 Total customers: 2,500 Value of claims filed $14B No. of patients: 48M lives No. of employees: 450 2015 CY Revenue $113M 2015 CY EBITDA ~$43M 2015 CY Recurring Revenue 80%+ Brightree by the N
Slide 6: Tax synergy – A benefit to cash flow and acquisition multiple
Tax synergy – A benefit to cash flow and acquisition multiple Brightree is structured as a limited liability company, allowing transaction to be treated as an asset sale for all tax purposes ResMed to receive a step-up in the cost basis of the assets being acquired ResMed expects a reduction in futu
Slide 7: Brightree - A leader in post-acute technology and solutions
Brightree - A leader in post-acute technology and solutions Leading cloud-based provider of HME billing, inventory management and accounts receivable software Recognized industry leader with broad customer and partnerships Leader in attractive market segments HME/DME billing and management Home heal
Slide 8: Brightree - Recognized industry leader with unmatched footprint
Brightree - Recognized industry leader with unmatched footprint Strong credentials and deep relationships with a diverse network of customers Thought Leadership Industry Recognition Large PAC Ecosystem Footprint 3 consecutive years 6 consecutive years 2 consecutive years 6 consecutive years 2,500+ P
Slide 9: Air Solutions - Combined solution delivers efficiency & profitability
Physician Referrals Document Mgmt Revenue Cycle Mgmt Inventory Mgmt Resupply Patient Collections Home Health & Hospice Brightree Core Platform Brightree Extended Services Air Solutions - Combined solution delivers efficiency & profitability ResMed Resupply RDM
Slide 10: After Closing – Expanded capabilities with little disruption
After Closing – Expanded capabilities with little disruption Brightree will operate as a separate entity Brightree’s suite of business management and clinical software will enhance Air Solutions Platform for our HME customers Brightree will expand ResMed’s capabilities to help customers be more prof
Slide 11: Questions & Answers
(>) Questions & Answers